Pfizer · NSE: PFIZER · BSE: 500680
Q1 FY21 results · Apr–Jun 2020
Pfizer reported revenue from operations of ₹514.89 crore (down 5.4% from Q1 FY20) and net profit of ₹124.45 crore (up 10.3% from Q1 FY20) for Q1 FY21 (Apr–Jun 2020), on a standalone basis.
| Item | Q1 FY21 | Q1 FY20 | YoY | Q4 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 514.89 | 544.40 | −5.4% | 502.01 | +2.6% |
| Other income | 17.20 | 35.83 | −52.0% | 45.22 | −62.0% |
| Total income | 532.09 | 580.23 | −8.3% | 547.23 | −2.8% |
| Profit before tax | 173.34 | 174.91 | −0.9% | 121.90 | +42.2% |
| Net profit for the period | 124.45 | 112.81 | +10.3% | 103.01 | +20.8% |
| EPS, basic (₹) | 27.20 | 24.66 | +10.3% | 22.52 | +20.8% |
| Net margin (%) | 24.2 | 20.7 | 20.5 |
Standalone
- Filed with BSE
- 27 Jul 2020, 19:16 IST
- Board meeting
- 27 Jul 2020
- Period
- 01 Apr 2020 to 30 Jun 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE